Comment on: “Premedication prior to PEG-asparaginase is cost effective in pediatric patients with acute lymphoblastic leukemia”

Wing H. Tong; Carin A. Uyl-De Groot

doi:10.1002/pbc.29474

Comment on: “Premedication prior to PEG-asparaginase is cost effective in pediatric patients with acute lymphoblastic leukemia”

Wing H. Tong^*, Carin A. Uyl-De Groot

^*Corresponding author for this work

Erasmus School of Health Policy & Management

Research output: Contribution to journal › Comment/Letter to the editor › Professional › peer-review

Original language	English
Article number	e29474
Journal	Pediatric Blood and Cancer
Volume	69
Issue number	4
DOIs	https://doi.org/10.1002/pbc.29474
Publication status	Published - Apr 2022

Bibliographical note

Funding Information:
The authors thank the anonymous reviewer(s). The views expressed are those of the authors and not necessarily those of the other relevant organizations.

Access to Document

10.1002/pbc.29474Licence: Unspecified

Cite this

@article{2f55b52b50794364935f17bbd3b9fad8,

title = "Comment on: “Premedication prior to PEG-asparaginase is cost effective in pediatric patients with acute lymphoblastic leukemia”",

author = "Tong, {Wing H.} and {Uyl-De Groot}, {Carin A.}",

note = "Funding Information: The authors thank the anonymous reviewer(s). The views expressed are those of the authors and not necessarily those of the other relevant organizations.",

year = "2022",

month = apr,

doi = "10.1002/pbc.29474",

language = "English",

volume = "69",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "4",

}

TY - JOUR

T1 - Comment on

T2 - “Premedication prior to PEG-asparaginase is cost effective in pediatric patients with acute lymphoblastic leukemia”

AU - Tong, Wing H.

AU - Uyl-De Groot, Carin A.

N1 - Funding Information: The authors thank the anonymous reviewer(s). The views expressed are those of the authors and not necessarily those of the other relevant organizations.

PY - 2022/4

Y1 - 2022/4

UR - http://www.scopus.com/inward/record.url?scp=85120918029&partnerID=8YFLogxK

U2 - 10.1002/pbc.29474

DO - 10.1002/pbc.29474

M3 - Comment/Letter to the editor

C2 - 34889044

AN - SCOPUS:85120918029

SN - 1545-5009

VL - 69

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - 4

M1 - e29474

ER -

Comment on: “Premedication prior to PEG-asparaginase is cost effective in pediatric patients with acute lymphoblastic leukemia”

Bibliographical note

Access to Document

Other files and links

Cite this